Pharmaceutical stocks draw growing buy interest

Published: 2007-05-01 06:59:00

Updated: 2007-05-01 06:59:00

Increased gains of Yuhan Corporation and other drug makers on a broader market rally have raised hopes that pharmaceutical stocks will outperform the market hit by a recent FTA and a government-led new drug pricing policy, the so-called positive list system.

Analysts said that the outlook for ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK